Abstract:Background:
Implantable cardiac sensors have shown promise in reducing rehospitalization for heart failure (HF), but the efficacy of noninvasive approaches has not been determined. The objective of this study was to determine the accuracy of noninvasive remote monitoring in predicting HF rehospitalization.
Methods:
The LINK-HF study (Multisensor Non-invasive Remote Monitoring for Prediction of Heart Failure Exacerbation) examined the performance of a pe… Show more
“…To overcome the limitations of single channel monitoring, multiparameter monitoring wearable devices are being investigated. The LINK-HF study used a multiparameter patch sensor with ECG monitoring, intrathoracic impedance detection, accelerometry and temperature sensor on 100 patients with heart failure [ 51 ••]. A machine learning algorithm was then used on the data to create a personalised baseline for each individual, and then, a further predictive algorithm for decompensation was derived which demonstrated a sensitivity of 76% and specificity of 85% for a decompensation alert 10 days before the event.…”
Section: Direct-to-consumer Devices and Their Potential Usementioning
Purpose of Review This review discusses how wearable devices-sensors externally applied to the body to measure a physiological signal-can be used in heart failure (HF) care. Recent Findings Most wearables are marketed to consumers and can measure movement, heart rate, and blood pressure; detect and monitor arrhythmia; and support exercise training and rehabilitation. Wearable devices targeted at healthcare professionals include ECG patch recorders and vests, patches, and textiles with in-built sensors for improved prognostication and the early detection of acute decompensation. Integrating data from wearables into clinical decision-making has been slow due to clinical inertia and concerns regarding data security and validity, lack of evidence of meaningful impact, interoperability, regulatory and reimbursement issues, and legal liability. Summary Although few studies have assessed how best to integrate wearable technologies into clinical practice, their use is rapidly expanding and may support improved decision-making by patients and healthcare professionals along the whole patient pathway.
“…To overcome the limitations of single channel monitoring, multiparameter monitoring wearable devices are being investigated. The LINK-HF study used a multiparameter patch sensor with ECG monitoring, intrathoracic impedance detection, accelerometry and temperature sensor on 100 patients with heart failure [ 51 ••]. A machine learning algorithm was then used on the data to create a personalised baseline for each individual, and then, a further predictive algorithm for decompensation was derived which demonstrated a sensitivity of 76% and specificity of 85% for a decompensation alert 10 days before the event.…”
Section: Direct-to-consumer Devices and Their Potential Usementioning
Purpose of Review This review discusses how wearable devices-sensors externally applied to the body to measure a physiological signal-can be used in heart failure (HF) care. Recent Findings Most wearables are marketed to consumers and can measure movement, heart rate, and blood pressure; detect and monitor arrhythmia; and support exercise training and rehabilitation. Wearable devices targeted at healthcare professionals include ECG patch recorders and vests, patches, and textiles with in-built sensors for improved prognostication and the early detection of acute decompensation. Integrating data from wearables into clinical decision-making has been slow due to clinical inertia and concerns regarding data security and validity, lack of evidence of meaningful impact, interoperability, regulatory and reimbursement issues, and legal liability. Summary Although few studies have assessed how best to integrate wearable technologies into clinical practice, their use is rapidly expanding and may support improved decision-making by patients and healthcare professionals along the whole patient pathway.
“…In the heart failure care field, wearable sensors coupled with ML analytics can be potentially used to improve clinical outcomes and reduce hospitalizations [ 36 – 38 ]. Heart failure is a chronic disease with acute exacerbations that reports high rates of hospitalization and mortality year after year (one-year hospital readmission rate of more than 50%, and one-year mortality rates of 30%) [ 39 ] and involves a worldwide expenditure of around $31 billion [ 40 ] yearly.…”
Section: Electronic Health: Mobile Health and Iotmentioning
confidence: 99%
“…Due to the high cost of hospitalizations (the average length is 5–10 days) [ 41 ] and the high rates of morbidity and mortality (especially between the elderly population), the potential of IoT-based devices stands out. In the LINK-HF study [ 36 ], it was demonstrated that machine learning models that use data from VitalPatch®, a wearable sensor, can more accurately forecast heart failure exacerbation than invasive devices. The sensor layer used in the mentioned study was made up of a multisensory patch placed on the chest that recorded physiological data.…”
Section: Electronic Health: Mobile Health and Iotmentioning
Cardiovascular disease (CVD), despite the significant advances in the diagnosis and treatments, still represents the leading cause of morbidity and mortality worldwide. In order to improve and optimize CVD outcomes, artificial intelligence techniques have the potential to radically change the way we practice cardiology, especially in imaging, offering us novel tools to interpret data and make clinical decisions. AI techniques such as machine learning and deep learning can also improve medical knowledge due to the increase of the volume and complexity of the data, unlocking clinically relevant information. Likewise, the use of emerging communication and information technologies is becoming pivotal to create a pervasive healthcare service through which elderly and chronic disease patients can receive medical care at their home, reducing hospitalizations and improving quality of life. The aim of this review is to describe the contemporary state of artificial intelligence and digital health applied to cardiovascular medicine as well as to provide physicians with their potential not only in cardiac imaging but most of all in clinical practice.
“…Es gelang sogar, das Risiko für eine erst Jahre später entstandene Herzinsuffizienz bei Patienten zu ermitteln, die zum Zeitpunkt der EKG-Aufzeichnung noch eine normale Pumpfunktion aufwiesen [3]. Mithilfe von Informationen aus einem Brustpatch, der neben EKG auch Temperatur, Hautimpedanz und Bewegung aufzeichnet, konnte in einer Studie an Herzinsuffizienzpatienten eine kardiale Dekompensation mit einem zeitlichen Vorlauf von knapp 7 Tagen vorhersagt werden [24]. Solch ein präziser Blick in die Zukunft erlaubt eine rechtzeitige medizinische Intervention, um zukünftige kardiale Dekompensation in diesem Patientenkollektiv zu verhindern.…”
eHealth-Smart Devices revolutionieren die Kardiologie Der Bereich eHealth erfährt eine rasante Entwicklung, und digitale Konzepte werden im Medizinsektor und in der Kardiologie zunehmend umgesetzt. Gerade Smart Devices wie Smartphones und Smartwatches spielen im eHealth-Bereich eine große Rolle, da sie von einem Großteil der Bevölkerung genutzt werden und sehr viele Anwendungsmöglichkeiten in einem Gerät bündeln. Dies führt dazu, dass auch die Industrie und die Patienten selbst den Einsatz dieser Geräte vorantreiben. Auch die großen kardiologischen Fachgesellschaften gehen davon aus, dass mobile Devices inklusive der dazugehörigen Apps bei der Kommunikation von medizinischen Informationen, Entscheidungsprozessen im klinischen Alltag und telemedizinischen Erfassen von Biosignalen entscheidende Fortschritte erzielen werden. Der folgende Beitrag zeigt, was heute schon möglich ist und welche Anwendungsmöglichkeiten in naher Zukunft zu erwarten sind.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.